nextMONARCH: Abemaciclib Monotherapy or Combined With Tamoxifen for Metastatic Breast Cancer
Erika Hamilton(Sarah Cannon), Miguel Martín(Hospital General Universitario Gregorio Marañón), Molly Catherine Hardebeck(Eli Lilly (United States)), Roberto Hegg, Özgür Özyılkan, Katarína Petráková(Masaryk Memorial Cancer Institute), Javier Cortés(Villa Maria Hospital), Jens Huober(University of St.Gallen), Guy Jérusalem(Centre Hospitalier Universitaire de Liège), Alexey Manikhas(Centrum Onkologii), Yi Lu(Shandong Provincial Hospital), Erica L. Johnston(Eli Lilly (United States)), Sonya C. Chapman(Eli Lilly (United States)), Melissa Bear(Eli Lilly (United States)), Shin‐Cheh Chen(Chang Gung University)
Cited by 42
Related Papers
Pembrolizumab for Early Triple-Negative Breast Cancer
|New England Journal of Medicine|2020|3.1k
Palbociclib and Letrozole in Advanced Breast Cancer
|New England Journal of Medicine|2016|2.9k
Breast cancer
|Nature Reviews Disease Primers|2019|2.9k